Development, validation and clinical application of a LC-MS/MS method for the simultaneous quantification of hydroxychloroquine and its active metabolites in human whole blood.

[1]  Gustavo H. Marín,et al.  New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles , 2013, PloS one.

[2]  W. Clarke,et al.  A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometry. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[3]  Philip Timmerman,et al.  The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation. , 2013, Bioanalysis.

[4]  J. Piette,et al.  Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study) , 2012, Annals of the rheumatic diseases.

[5]  W. V. van Dongen,et al.  LC-MS systems for quantitative bioanalysis. , 2012, Bioanalysis.

[6]  S. Digumarthy,et al.  A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non–Small-Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  D. Lipsker,et al.  Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study. , 2012, Archives of dermatology.

[8]  S. Chan,et al.  Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometry. , 2012, Journal of pharmaceutical and biomedical analysis.

[9]  Achille Cappiello,et al.  An overview of matrix effects in liquid chromatography-mass spectrometry. , 2011, Mass spectrometry reviews.

[10]  B. Mégarbane,et al.  Blood concentrations are better predictors of chioroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration/effect relationships , 2010, Clinical toxicology.

[11]  Y. Michotte,et al.  Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Jae-Won Park,et al.  Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax , 2009, Antimicrobial Agents and Chemotherapy.

[13]  N. Buckley,et al.  Survival after Massive Hydroxychloroquine Overdose , 2009, Anaesthesia and intensive care.

[14]  D. Raoult,et al.  Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century , 2007, International Journal of Antimicrobial Agents.

[15]  F. Derderian,et al.  Traitement d'une intoxication à l'hydroxychloroquine par circulation extracorporelle , 2007 .

[16]  J. Piette,et al.  Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[17]  B. Mégarbane,et al.  [Acute hydroxychloroquine poisoning. The danger of rapid or excessive correction of initial hypokalemia]. , 2005, Presse medicale.

[18]  ScienceDirect.  EMC. Anesthésie-réanimation , 2005 .

[19]  R. Atilla,et al.  Massive hydroxychloroquine overdose , 2004, Acta anaesthesiologica Scandinavica.

[20]  G. Hopfgartner,et al.  Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry. , 2003, Mass spectrometry reviews.

[21]  I. Whyte,et al.  Hydroxychloroquine overdose: a prospective case series. , 2002, The American journal of emergency medicine.

[22]  M. Weisman,et al.  Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[23]  T. Albertson,et al.  Treatment of hydroxychloroquine overdose. , 2001, The American journal of emergency medicine.

[24]  D. L. Le Couteur,et al.  Hydroxychloroquine overdose: toxicokinetics and management. , 1999, Journal of toxicology. Clinical toxicology.

[25]  S. van der Linden,et al.  [A patient with acute hydroxychloroquine poisoning; recommendation for treatment]. , 1990, Nederlands tijdschrift voor geneeskunde.

[26]  A. V. Kemmenoe.  An infant fatality due to hydroxychloroquine poisoning. , 1990, Journal of analytical toxicology.

[27]  R. Day,et al.  A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. , 1988, British journal of clinical pharmacology.

[28]  S. Williams,et al.  Analysis of blood and urine samples for hydroxychloroquine and three major metabolites by high-performance liquid chromatography with fluorescence detection. , 1988, Journal of chromatography.

[29]  D. Cutler,et al.  High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at pH 11, with fluorimetric detection. , 1985, Journal of chromatography.

[30]  A. Maehly,et al.  Two fatal poisonings by chloroquine and by hydroxychloroquine. , 1965, Journal - Forensic Science Society.

[31]  D. Hainsworth,et al.  FATAL PLAQUENIL POISONING. , 1965, Journal - Forensic Science Society.